BellRing Brands (BRBR) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
9 Jul, 2026Executive summary
Q2 net sales rose 19% year-over-year to $588 million, driven by strong Premier Protein volume growth and targeted price increases, with net earnings up 3% to $58.7 million and operating profit at $95.1 million.
Premier Protein shakes saw 25% consumption growth, reaching record highs in household penetration (20.9%) and market share, while Dymatize returned to growth with new RTD launches.
The company reaffirmed its FY2025 outlook for net sales growth of 13%–17% ($2.26–$2.34 billion) and adjusted EBITDA growth of 7%–14% ($470–$500 million).
Category fundamentals remain robust, with convenient nutrition and RTD segments showing double-digit growth and Premier Protein leading in tracked market share.
Risks include input cost inflation, supply chain disruptions, and changing consumer preferences.
Financial highlights
Q2 net sales were $588 million (+19% YoY); adjusted EBITDA was $119 million (+14% YoY) with a 20.2% margin.
Adjusted gross profit grew 22% to $203 million (34.5% margin); Q2 gross profit was $189.8 million (32.3% margin).
Q2 net earnings were $58.7 million (+3% YoY); diluted EPS was $0.45.
SG&A expenses rose to $91 million, mainly due to higher advertising and warehousing costs.
Cash flow from operations was $48 million in Q2 and $51 million for the first half.
Outlook and guidance
FY2025 guidance affirmed: net sales of $2.26–$2.34 billion and adjusted EBITDA of $470–$500 million.
Second half net sales outlook unchanged, with Q3 growth expected in low single digits due to retailer inventory reductions.
Adjusted EBITDA margins for the second half expected just over 20%, with margin pressure from input-cost inflation and increased promotional spend.
No significant capital expenditures planned for the next 12 months; focus on working capital, debt service, and share repurchases.
No expected tariff impact in FY2025; partial impact possible in 2026, with mitigation strategies under evaluation.
Latest events from BellRing Brands
- Strong 2025 sales and brand momentum, with 2026 guidance showing growth and margin pressure.BRBR
Q4 20259 Jul 2026 - Premier Protein drove strong sales and EBITDA growth, with double-digit 2025 outlook despite margin pressures.BRBR
Q4 20248 Jul 2026 - Net sales up 1% to $537.3M, margins fell, 2026 outlook narrowed, CEO transition and settlements announced.BRBR
Q1 20268 Jul 2026 - Net sales and earnings surged, guidance raised, and Premier Protein drove record growth.BRBR
Q3 20248 Jul 2026 - Q2 sales rose 2% but margins and earnings fell sharply amid inflation and inventory charges.BRBR
Q2 20265 May 2026 - All proposals passed with strong support and no shareholder questions were raised.BRBR
AGM 20263 Feb 2026 - Q1 net sales up 24% and net earnings up 75%, with FY25 outlook raised on Premier Protein strength.BRBR
Q1 20258 Jan 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay; online access promoted.BRBR
Proxy Filing16 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and approve pay, with focus on governance and ESG.BRBR
Proxy Filing16 Dec 2025